Filtered By:
Cancer: Cancer
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 1392 results found since Jan 2013.
Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives
J Formos Med Assoc. 2023 Jul 12:S0929-6646(23)00246-2. doi: 10.1016/j.jfma.2023.06.018. Online ahead of print.ABSTRACTSince government-provided annual cervical cytology testing for all Taiwanese women aged 30 years or older became available in 1995, both cervical cancer incidence and death have decreased significantly. However, with the 2018 introduction of the national immunization program for human papillomavirus (HPV) vaccination in all schoolgirls aged 13-15 years old, the positive predictive value of cytology testing is expected to decrease with rising vaccination rates, and therefore a transition to more sensitive HP...
Source: J Formos Med Assoc - July 14, 2023 Category: General Medicine Authors: Chien-Chin Chen Chyong-Huey Lai Chih-Long Chang Wen-Fang Cheng Raoh-Fang Pwu Jane Tsai Peng-Hui Wang Jacqueline Whang-Peng Gi-Ming Lai Source Type: research
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021
Curr Med Chem. 2023 Jul 13. doi: 10.2174/0929867331666230713165407. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) infections are the cause of warts, lesions and cancer, with different types of HPV causing different symptoms. HPV infections are the primary cause of cervical cancer. There are over 220 different types of HPV, and only nine of these can currently be vaccinated. There is a need to treat these viral infections without just treating the symptoms of the infection, as is currently the main method. There is a wide range of small molecules that have been used to inhibit various stages of the HPV infectious...
Source: Current Medicinal Chemistry - July 14, 2023 Category: Chemistry Authors: Caitlin L Duncan Hendra Gunosewoyo Mauro Mocerino Alan D Payne Source Type: research
Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives
J Formos Med Assoc. 2023 Jul 12:S0929-6646(23)00246-2. doi: 10.1016/j.jfma.2023.06.018. Online ahead of print.ABSTRACTSince government-provided annual cervical cytology testing for all Taiwanese women aged 30 years or older became available in 1995, both cervical cancer incidence and death have decreased significantly. However, with the 2018 introduction of the national immunization program for human papillomavirus (HPV) vaccination in all schoolgirls aged 13-15 years old, the positive predictive value of cytology testing is expected to decrease with rising vaccination rates, and therefore a transition to more sensitive HP...
Source: J Formos Med Assoc - July 14, 2023 Category: General Medicine Authors: Chien-Chin Chen Chyong-Huey Lai Chih-Long Chang Wen-Fang Cheng Raoh-Fang Pwu Jane Tsai Peng-Hui Wang Jacqueline Whang-Peng Gi-Ming Lai Source Type: research
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021
Curr Med Chem. 2023 Jul 13. doi: 10.2174/0929867331666230713165407. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) infections are the cause of warts, lesions and cancer, with different types of HPV causing different symptoms. HPV infections are the primary cause of cervical cancer. There are over 220 different types of HPV, and only nine of these can currently be vaccinated. There is a need to treat these viral infections without just treating the symptoms of the infection, as is currently the main method. There is a wide range of small molecules that have been used to inhibit various stages of the HPV infectious...
Source: Current Medicinal Chemistry - July 14, 2023 Category: Chemistry Authors: Caitlin L Duncan Hendra Gunosewoyo Mauro Mocerino Alan D Payne Source Type: research
Clinical Characteristics of Human Papillomavirus Infection in the Male Genital Tract
CONCLUSIONS: The rates of male HPV infection are high, particularly among individuals aged 17-40. Low-risk infections (types 6 and 11) cause male reproductive tract symptoms, including abnormal growth. High-risk infection (HPV52) correlates with local women's HPV subtype distribution and potential transmission. Therefore, screening for male HPV infection is crucial in preventing cervical cancer. Authorities should promote the development and early use of male HPV vaccines.PMID:37442188
Source: Alternative Therapies in Health and Medicine - July 13, 2023 Category: Complementary Medicine Authors: Tiantian Gou Ping Liu Xiuju Yao Lin Zhang Source Type: research
Awareness, perceptions, and acceptance of human papillomavirus vaccination among parents in Hong Kong
CONCLUSION: Parents in Hong Kong are hesitant about HPV vaccination for their sons. This barrier could be removed by providing information to correct vaccine safety misconceptions and offering a gender-neutral vaccination programme through the school-based Childhood Immunisation Programme.PMID:37409372 | DOI:10.12809/hkmj2210470
Source: Hong Kong Med J - July 6, 2023 Category: General Medicine Authors: E W H Lam H Y S Ngan K Y Kun D F H Li W Y Wan P K S Chan Source Type: research
Systematic literature review of primary and secondary cervical cancer prevention programs in South America
CONCLUSIONS: No documents were found about a national HPV vaccination program in French Guiana and Venezuela, and no official guidelines for cervical cancer screening were found for Suriname and Venezuela; thus, it will be difficult to eliminate this public health problem in these countries. Countries in South America must update their guidelines for HPV vaccination and cervical cancer screening as new evidence emerges. Official websites with information about HPV vaccination and cervical cancer screening are important sources that can be accessed by health professionals and the population.PMID:37405122 | PMC:PMC10317248 |...
Source: Pan American Journal of Public Health - July 5, 2023 Category: International Medicine & Public Health Authors: Maria Luziene de Sousa Gomes N ádya Dos Santos Moura Let ícia de Carvalho Magalhães Roger Rodrigues da Silva B árbara Gomes Santos Silva Ivana Rios Rodrigues Luiz Belino Ferreira Sales M ônica Oliveira Batista Oriá Source Type: research
